GlassScriptPhysician profile
Silvania C Ng
NPI 1053386540
$32,892.89
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $9,477 · 2021: $2,948 · 2022: $679.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $15,555.18 | 2019-2022 | |
| Allergan, INC. | $6,718.11 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $4,219.53 | 2019-2022 | |
| Abbvie INC. | $1,849.87 | 2021-2022 | |
| Gilead Sciences, INC. | $1,458.85 | 2019-2022 | |
| Viiv Healthcare Company | $728.96 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $612.35 | 2019-2022 | |
| Theratechnologies INC. | $415.51 | 2019-2021 | |
| Shionogi INC | $316.87 | 2019-2022 | |
| Nabriva Therapeutics, Plc | $298.48 | 2020 | |
| Janssen Products, LP | $244.41 | 2019 | |
| Melinta Therapeutics, LLC | $144.98 | 2019 | |
| Sanofi Pasteur INC. | $114.74 | 2022 | |
| Mayne Pharma Commercial LLC | $89.96 | 2019-2022 | |
| La Jolla Pharmaceutical Company | $43.33 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tetraphase Pharmaceuticals, INC. | $20.65 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $20.00 | 2019 | |
| Vyera Pharmaceuticals, LLC | $19.50 | 2019 | |
| Janssen Biotech, INC. | $12.91 | 2019 | |
| Dynavax Technologies Corporation | $8.70 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Silvania Ng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.